KLF5 can promote the epithelial-mesenchymal transition (EMT) (46), a process crucial for melanoma invasion and metastasis (47), making it a potential target for therapeutic interventions aimed at disrupting these pathways. The gene discussed is KLF5; the disease is melanoma.